These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16029222)

  • 1. Effect of atorvastatin and fluvastatin on the metabolism of midazolam by cytochrome P450 in vitro.
    Mc Donnell CG; Shorten G; Van Pelt FN
    Anaesthesia; 2005 Aug; 60(8):747-53. PubMed ID: 16029222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of different CYP enzymes in the formation of specific fluvastatin metabolites by human liver microsomes.
    Toda T; Eliasson E; Ask B; Inotsume N; Rane A
    Basic Clin Pharmacol Toxicol; 2009 Nov; 105(5):327-32. PubMed ID: 19663817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic interactions between mibefradil and HMG-CoA reductase inhibitors: an in vitro investigation with human liver preparations.
    Prueksaritanont T; Ma B; Tang C; Meng Y; Assang C; Lu P; Reider PJ; Lin JH; Baillie TA
    Br J Clin Pharmacol; 1999 Mar; 47(3):291-8. PubMed ID: 10215754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of HMGCoA reductase inhibitors on cytochrome P450 expression in endothelial cell line.
    Bertrand-Thiebault C; Masson C; Siest G; Batt AM; Visvikis-Siest S
    J Cardiovasc Pharmacol; 2007 May; 49(5):306-15. PubMed ID: 17513950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin: effect on human cytochrome P-450 and implications for metabolic drug interactions.
    Fischer V; Johanson L; Heitz F; Tullman R; Graham E; Baldeck JP; Robinson WT
    Drug Metab Dispos; 1999 Mar; 27(3):410-6. PubMed ID: 10064574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins.
    Dansette PM; Jaoen M; Pons C
    Exp Toxicol Pathol; 2000 May; 52(2):145-8. PubMed ID: 10965989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) as inhibitors of cytochrome P450 2C8.
    Tornio A; Pasanen MK; Laitila J; Neuvonen PJ; Backman JT
    Basic Clin Pharmacol Toxicol; 2005 Aug; 97(2):104-8. PubMed ID: 15998357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the pharmacodynamic and pharmacokinetic properties of statins.
    Corsini A; Bellosta S; Baetta R; Fumagalli R; Paoletti R; Bernini F
    Pharmacol Ther; 1999 Dec; 84(3):413-28. PubMed ID: 10665838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluvastatin and atorvastatin affect calcium homeostasis of rat skeletal muscle fibers in vivo and in vitro by impairing the sarcoplasmic reticulum/mitochondria Ca2+-release system.
    Liantonio A; Giannuzzi V; Cippone V; Camerino GM; Pierno S; Camerino DC
    J Pharmacol Exp Ther; 2007 May; 321(2):626-34. PubMed ID: 17293561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of statins on fibroblasts from human nasal polyps and turbinates.
    Folli C; Descalzi D; Bertolini S; Riccio AM; Scordamaglia F; Gamalero C; Barbieri M; Passalacqua G; Canonica GW
    Eur Ann Allergy Clin Immunol; 2008 Nov; 40(3):84-9. PubMed ID: 19334372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
    Turner NA; Midgley L; O'Regan DJ; Porter KE
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactonization is the critical first step in the disposition of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin.
    Jacobsen W; Kuhn B; Soldner A; Kirchner G; Sewing KF; Kollman PA; Benet LZ; Christians U
    Drug Metab Dispos; 2000 Nov; 28(11):1369-78. PubMed ID: 11038166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of concurrent atorvastatin therapy on the pharmacokinetics of intravenous midazolam.
    Mc Donnell CG; Harte S; O'Driscoll J; O'Loughlin C; Van Pelt FN; Shorten GD
    Anaesthesia; 2003 Sep; 58(9):899-904. PubMed ID: 12911366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo inhibition profile of cytochrome P450TB (CYP2C9) by (+/-)-fluvastatin.
    Transon C; Leemann T; Vogt N; Dayer P
    Clin Pharmacol Ther; 1995 Oct; 58(4):412-7. PubMed ID: 7586933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro.
    Demyanets S; Kaun C; Pfaffenberger S; Hohensinner PJ; Rega G; Pammer J; Maurer G; Huber K; Wojta J
    Biochem Pharmacol; 2006 Apr; 71(9):1324-30. PubMed ID: 16540096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and fenofibrate affect skeletal muscle chloride conductance in rats by differently impairing ClC-1 channel regulation and expression.
    Pierno S; Camerino GM; Cippone V; Rolland JF; Desaphy JF; De Luca A; Liantonio A; Bianco G; Kunic JD; George AL; Conte Camerino D
    Br J Pharmacol; 2009 Apr; 156(8):1206-15. PubMed ID: 19220292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors.
    Transon C; Leemann T; Dayer P
    Eur J Clin Pharmacol; 1996; 50(3):209-15. PubMed ID: 8737761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells.
    Lopez S; Peiretti F; Bonardo B; Juhan-Vague I; Nalbone G
    Atherosclerosis; 2000 Oct; 152(2):359-66. PubMed ID: 10998463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research on the effect of statins on insulin secretion from pancreatic islet in rats and its mechanisms].
    Chang BC; Zheng MY; Shan CY; Yang JH; Wang Y; Ren HZ; Chen LM; Fang PH
    Zhonghua Nei Ke Za Zhi; 2011 May; 50(5):393-6. PubMed ID: 21624221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel incubation direct injection LC/MS/MS technique for in vitro drug metabolism screening studies involving the CYP 2D6 and the CYP 3A4 isozymes.
    Bhoopathy S; Xin B; Unger SE; Karnes HT
    J Pharm Biomed Anal; 2005 Apr; 37(4):739-49. PubMed ID: 15797796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.